Horizon boosts portfolio with Vidara merger

20-03-2014

Horizon boosts portfolio with Vidara merger

Photo: alphaspirit / Shutterstock.com

Horizon Pharma is set to acquire Dublin-based Vidara Therapeutics in a merger worth about $660 million, the companies announced on March 19.


Horizon Pharma, Vidara Therapeutics, Actimmune, merger, M&A

LSIPR